In addition, the status of IDH type and 1p/19q co-deletion among tumors could be distinguished by risk scores; IDH wild type and 1p19q non-co-deletion gliomas were the poor prognostic factors and had an inadequate response to traditional radiotherapy or chemotherapy of LGG patients (Li Y. et al., 2020). The gene discussed is IDH1; the disease is central nervous system cancer.